(0) Write a review
In stock

Tirzepatide 5 Mg

Tirzepatide 5mg Dual GIP/GLP-1 Receptor Agonist Peptide.

$52.00

13 products sold in last 24 hours
32 people are viewing this right now
Buy now
QuantityDiscountPrice
3–58%$47.84
6–910%$46.80
10+12%$45.76
Discount is applied automatically at checkout based on the quantity in your cart.
Ask Us
Product SpecificationTirzepatide 5mg / Lyophilized Powder Vial
Biochemical EngineDual GIP and GLP-1 Receptor Agonist Peptide
Primary Assay TargetInvestigated for synergistic incretin pathway activation, metabolic regulation, and energy homeostasis
Logistics ProfileTemperature-insulated, secure vacuum dispatch with complete tracking

STRICTLY FOR LABORATORY RESEARCH: This synthetic agent is processed strictly for institutional R&D, high-precision in vitro calibrations, and testing lines. Not for human therapeutic or diagnostic use.

Brand:

Description

Tirzepatide 5mg Core Specifications

Deep technical specification parameters optimized for integrating 5mg Tirzepatide into focused laboratory screening protocols.

Research ParameterAssay Benchmark ProfileInternal Catalog Link
Sequence BlueprintC-Terminal Acylated Polypeptide (Dual-Acting 39 Amino Acid Linear Base)High-Purity Series →
Molecular Weight4813.5 Da (Stabilized with a functional C20 fatty diacid tail chain)
Purity Baseline≥ 98.0% via High-Performance SEC-HPLCMetabolic – Weight Loss Series →
Assay TargetSynergistic GIP & GLP-1 Receptor Activation Loops (Zero CNS Shock)

Tirzepatide 5mg is a precision-engineered dual incretin agonist synthesized to concurrently target Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) receptor systems. By co-activating these two distinct metabolic pathways, this acylated 39-amino-acid peptide offers a pristine baseline for analyzing intracellular cAMP signaling, glucose-dependent insulin release, and adipocyte lipid mobilization. Formulated as a freeze-dried, sterile lyophilized solid, this 5mg vial configuration provides an optimal low-dose footprint for early titration studies, baseline receptor binding assays, and preliminary cell-culture screens without risking product waste or long-term liquid degradation. To inspect batch analytical documentation, visit peptidesk.com.

Tirzepatide 5mg Technical Specifications

Technical PropertyLaboratory Standard Specifications
Chemical StructureAcylated 39-Amino Acid Dual Agonist Sequence
Active Core Payload5mg Lyophilized Crystalline Powder / Vial
Purity Baseline≥ 98.0% Pure Certified via HPLC & Mass Spectrometry
Primary Target NodeSynergistic GIPR/GLP-1R activation & baseline lipid clearance

Research Compliance Notice: Compounds listed as tirzepatide research peptide for sale or tirzepatide 5mg for sale are provided strictly for in vitro cellular profiling, metabolic research, and laboratory assays. They are strictly not approved for clinical human administration, therapeutic use, or self-medication.

How Does Tirzepatide 5mg Work in Cellular Assays?

The cellular tirzepatide mechanism of action relies on its ability to stimulate dual incretin receptor networks simultaneously. Unlike selective single-receptor mimetics, Tirzepatide activates complimentary biological cascades:

  • GIP Receptor Agonism: Interacts with GIP receptors on pancreatic beta cells and adipocytes, facilitating glucose-dependent insulin secretion and regulating fatty acid utilization.
  • GLP-1 Receptor Activation: Stimulates GLP-1 surface receptors to engage adenylate cyclase signaling, elevating intracellular cyclic AMP (cAMP) levels, slowing gastric transit, and modulating hypothalamic satiety nodes.
  • Synergistic Receptor Sync: Concurrent activation across both incretin pathways drives enhanced metabolic responsiveness and glucose stability in research models.

Tirzepatide 5mg Target Pathways & Action Matrix

Target PathwayObserved Cellular ActionPrimary Research Goal
Dual Incretin ActivationSimultaneous GIPR and GLP-1R stimulation drives downstream cAMP flux.Analyzing dual-receptor cross-talk in cell cultures.
Lipid MobilizationPromotes fatty acid oxidation and triglyceride breakdown in target cell lines.Measuring lipid accumulation reduction rates.
Gastric Motility DelayMonitors transit deceleration curves across gastrointestinal tissue models.Establishing digestive transit baselines.

Tirzepatide 5mg Research Applications & Clinical Data

Clinical trial literature exploring tirzepatide for weight loss models highlights profound reductions in total body mass and metabolic risk markers. Major clinical findings include:

  • Significant Weight Reduction: In clinical trial cohorts (such as the landmark SURMOUNT studies), step-wise dose escalation achieved body weight reductions exceeding 20% over 72-week evaluation timelines.
  • Biomarker Enhancements: Data records document substantial improvements in HbA1c, fasting plasma insulin, and visceral fat distribution.
  • Practical 5mg Entry Format: The 5mg presentation provides an ideal entry-level vial footprint for laboratories setting up early-phase dose-response studies and baseline calibrations.

Tirzepatide 5mg vs. Mounjaro: Understanding the Differences

When assessing mounjaro vs tirzepatide in scientific contexts, researchers must differentiate between commercial pharmaceutical preparations and analytical laboratory reagents:

Comparison AttributeMounjaro / ZepboundTirzepatide 5mg Research Peptide
Active SequenceTirzepatide active chemical sequence.Identical 39-amino acid acylated sequence.
Delivery SystemPre-filled clinical single-dose autoinjector pen.Freeze-dried crystalline powder vial (5mg).
Application FieldClinical prescription therapy for T2D & obesity.In vitro research, receptor binding & cellular assays.

Tirzepatide 5mg vs. Semaglutide: Multi-Receptor Comparison

Comparing tirzepatide vs semaglutide illustrates how dual incretin engagement offers greater metabolic flexibility than single GLP-1 receptor activation:

CompoundTarget ReceptorsResearch BenchmarkStructure
Tirzepatide 5mg(Dual Agonist)GIPR + GLP-1RDual incretin engagement achieving superior metabolic & weight reduction data.39-AA Acylated Peptide
SemaglutideGLP-1R SelectiveMono-incretin standard evaluated across glucose management models.31-AA Acylated Peptide
Orforglipron 6mgGLP-1R (Oral)Non-peptide small molecule studied in oral transit modeling.Small Molecule

Tirzepatide 5mg vs. Retatrutide: Dual vs. Triple Agonism

When analyzing multi-target peptide mimetics, scientists evaluate dual-action Tirzepatide (GIPR/GLP-1R) against triple-action Retatrutide (GIPR/GLP-1R/GCGR). While Tirzepatide effectively balances insulin sensitivity and satiety signaling, Retatrutide incorporates direct Glucagon receptor agonism to further elevate lipid oxidation and basal energy expenditure.

Tirzepatide 5mg Dosing Protocols & Escalation Schedules

In clinical research protocols, establishing proper tirzepatide dosing follows a structured titration timeline designed to build metabolic tolerance while minimizing GI friction:

  1. Initiation Step (Weeks 1–4): Started at a low baseline dose of 2.5mg weekly to allow initial tissue receptor adjustment.
  2. Step-Up Titration (Weeks 5+): Increased by 2.5mg increments every 4 weeks (progressing through 5mg, 7.5mg, 10mg, and 12.5mg tiers).
  3. Peak Maintenance Level (15mg Weekly): Reaches maximum clinical maintenance doses at 15mg weekly for peak incretin activation.

Tirzepatide 5mg Side Effects & Safety Profile

Documenting tirzepatide side effects is a standard requirement in trial logging. Preclinical and clinical observations report the following parameters:

  • Gastrointestinal Responses: Mild to moderate nausea, vomiting, diarrhea, or constipation, occurring primarily during initial dose escalation phases.
  • Systemic Observations: Transient fatigue or mild headaches secondary to rapid caloric deficit transitions.
  • Tolerability Management: Adhering to step-wise dose escalation significantly improves overall gastrointestinal tolerance.

Tirzepatide 5mg Storage & Handling Parameters

  • FREEZER (-20°C)
    Lyophilized Powder: Store unopened powder vials inside a laboratory freezer at -20°C to -80°C for long-term stability up to 24 months.
  • TRANSIT RESILIENCE
    Unreconstituted Powder: Highly resilient during shipping; can withstand room temperatures up to 25°C for up to 3 weeks. Return to freezer upon receipt.
  • REFRIGERATOR (2°C – 8°C)
    Reconstituted Solution: Store liquid solutions under refrigeration between 2°C and 8°C. Exhaust active liquid within 10 to 14 days. Do not refreeze.

Step-by-Step Reconstitution Protocol for Tirzepatide 5mg

  1. Allow the 5mg vial to naturally reach room temperature before removing the flip-off seal.
  2. Swab the upper rubber stopper using a sterile isopropyl alcohol wipe.
  3. Slowly inject sterile bacteriostatic water down the inside glass wall to prevent mechanical shock.
  4. Do not shake. Gently swirl the vial horizontally in circular motions until dissolved into a clear liquid.

Analytical Verification & Lab Reports: Inspect our latest batch HPLC purity charts, mass spectrometry results, and independent Certificates of Analysis (COA) directly on our PeptidesK Third-Party Lab Testing Page.

To buy tirzepatide 5mg or source high-purity research compounds backed by certified batch HPLC reports and fast domestic shipping, order directly from peptidesk.com.

Shop by Goal Categories

Explore our high-purity research compounds and peptides categorized by primary experimental targets and research goals:

Goal CategoryPrimary Research Focus
Anti-Aging & Longevity Peptides →Cellular renewal, telomere maintenance, and anti-senescence research models.
Fat Loss & Metabolic Peptides →Incretin mimetics, lipolysis acceleration, and metabolic flexibility profiling.
Muscle Growth & Building Peptides →Anabolic signaling, GH secretagogues, and protein synthesis acceleration.
Recovery & Healing Peptides →Soft tissue repair, tendon-to-bone recovery, and systemic cell migration.
Focus & Cognitive Peptides →Nootropic signaling, neuroprotection, and synaptic plasticity assays.

Why Buy PeptidesK Tirzepatide 5mg Online?

Why Buy PeptidesK Tirzepatide 5mg Online?

Establishing baseline parameters in cellular metabolic assays requires precision-engineered reagents in lower dosage increments. PeptidesK Tirzepatide 5mg offers laboratories an essential entry-level concentration of this dual GIP and GLP-1 receptor agonist, formulated to deliver high chemical stability and exact stoichiometry during analytical evaluations.

Quality control is embedded in every stage of our supply chain at PeptidesK. Each production run of Tirzepatide 5mg is independently verified through quantitative laboratory assays to ensure complete sequence accuracy, optimal solubility, and zero impurities. By selecting PeptidesK, your institution gains reference materials that yield consistent, reproducible experimental findings across multiple trial series.

Purchasing your scientific reference standards through PeptidesK guarantees key advantages for your lab:

  • ✔ Comprehensive Certificate of Analysis: Fully transparent HPLC and Mass Spectrometry validation provided per lot.
  • ✔ Protected & Express Transit: Quick order dispatch in climate-conscious packaging to safeguard compound structural integrity.
  • ✔ Dedicated Service & Discounts: 24/7 technical customer assistance along with instant checkout savings on Crypto payments.

Accelerate your metabolic peptide studies today—order analytical-grade Tirzepatide 5mg directly from PeptidesK for rapid shipping and certified purity.

Frequently Asked Questions (FAQ)

1. What role does Tirzepatide 5mg play in laboratory research?

Tirzepatide 5mg provides an ideal initial concentration for examining dual GIP and GLP-1 receptor co-agonism. Researchers frequently use this format for initial baseline assays, binding kinetic measurements, and dose-response modeling.

2. Why choose PeptidesK for ordering Tirzepatide 5mg?

PeptidesK stands out by delivering verified batch purity, accessible CoA documentation, fast order processing, and a reliable e-commerce platform built for scientific facilities.

3. What are the proper storage conditions for Tirzepatide 5mg?

Keep lyophilized vials sealed in a cool, dark place. For long-term shelf preservation, maintain the product under refrigeration at 2°C to 8°C away from humidity.

4. Is a batch-specific Certificate of Analysis available?

Yes. Every unit of Tirzepatide 5mg distributed by PeptidesK includes HPLC chromatograms and Mass Spectrometry analysis verifying >99% chemical purity.

5. What are the shipping timeline expectations?

Orders are processed within 24 to 48 hours and shipped via express courier channels in thermal-buffered packaging to prevent environmental stress.

6. Is Tirzepatide 5mg suitable for clinical or personal use?

No. All peptide formulations provided by PeptidesK, including Tirzepatide 5mg, are intended exclusively for in-vitro laboratory research and scientific trials. They are not cleared for human consumption.

Reviews

Be the first to review “Tirzepatide 5 Mg”

Your email address will not be published. Required fields are marked *

There are no reviews yet.

Search

Back to Top
Product has been added to your cart
Compare (0)